Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
Pdgfrb
REST API REST API
Mus musculus
Pdgfrb is differentially expressed in 247 experiments: 103 organism parts: liver, kidney, ... (101 more);, 15 disease states: normal, 3-NP-induced neurodegeneration model of Huntington's disease, ... (13 more);, 62 cell types 22 cell lines 47 compound treatments and 35 other conditions.
Synonyms 'CD140b', 'Pdgfr'
Orthologs PDGFRB (Homo sapiens)   F1N868_CHICK (Gallus gallus)   F1MBP1_BOVIN (Bos taurus)   Pdgfrb (Rattus norvegicus)   Pvr (Drosophila melanogaster)   PDGFRB (Xenopus laevis)   (Compare orthologs)
Gene Ontology Term plasma membrane, phosphorylation, protein binding, cytoplasm, positive regulation of cell proliferation, membrane, peptidyl-tyrosine phosphorylation, protein tyrosine kinase activity, transforming growth factor beta receptor signaling pathway, receptor binding, positive regulation of MAP kinase activity, transmembrane receptor protein tyrosine kinase signaling pathway, glycosaminoglycan biosynthetic process, signal transducer activity, hemopoiesis, ATP binding, transferase activity, transferring phosphorus-containing groups, integral to plasma membrane, nucleus, receptor activity, nucleotide binding, kinase activity, protein serine/threonine kinase activity, transmembrane receptor protein tyrosine kinase activity, apical plasma membrane, transferase activity, integral to membrane, tissue homeostasis, regulation of actin cytoskeleton organization, nitrogen compound metabolic process, signal transduction, protein kinase activity, intracellular protein kinase cascade, cell chemotaxis, positive regulation of smooth muscle cell migration, in utero embryonic development, regulation of peptidyl-tyrosine phosphorylation, platelet-derived growth factor beta-receptor activity, kidney development, positive regulation of ERK1 and ERK2 cascade, positive regulation of collagen biosynthetic process, adrenal gland development, platelet-derived growth factor receptor signaling pathway, positive regulation of cell migration, positive regulation of anti-apoptosis, cardiac myofibril assembly, positive regulation of chemotaxis, smooth muscle tissue development, growth factor binding, platelet-derived growth factor binding, skeletal system morphogenesis, positive regulation of smooth muscle cell proliferation, vascular endothelial growth factor receptor signaling pathway, platelet-derived growth factor receptor binding, positive regulation of mitosis, protein autophosphorylation, protein phosphorylation, retina vasculature development in camera-type eye, positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway, metanephric glomerular mesangial cell proliferation involved in metanephros development, platelet-derived growth factor receptor-beta signaling pathway, cardiac vascular smooth muscle cell differentiation, positive regulation of reactive oxygen species metabolic process, metanephric glomerular capillary formation, positive regulation of calcium ion import, phosphatidylinositol 3-kinase binding, positive regulation of phosphatidylinositol 3-kinase cascade, positive regulation of DNA biosynthetic process, aorta morphogenesis, smooth muscle cell chemotaxis, metanephric mesenchymal cell migration, vascular endothelial growth factor-activated receptor activity, platelet-derived growth factor-activated receptor activity
InterPro Term Ig_sub, Immunoglobulin, Prot_kinase_cat_dom, Ig-like, Ig_sub2, Ig_I-set, Tyr_kinase_VEGFR_rcpt_N, Ser/Thr_kinase_dom, Tyr_kinase_cat_dom, Ser-Thr/Tyr_kinase, Tyr_kinase_CSF1/PDGF_rcpt, Se/Thr_kinase-like_dom
Search EB-eye ENSMUSG00000024620
Show more properties
Experimental Factors
Organism part

studied in E-TABM-1039, E-GEOD-20160, E-GEOD-3963, E-GEOD-2161, E-MEXP-1636, ... (56 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17112, E-GEOD-21515, E-GEOD-19732, E-GEOD-1956, E-GEOD-10246, ... (9 experiments)

Factor Value U/D Experiments
C3H_10T1_2
1
E-GEOD-10246
67NR
1
1
E-GEOD-11259
lewis lung carcinoma (LLC)
1
E-GEOD-17112
N1E-115 wild_type
1
E-GEOD-1956
N1E-115 Tcof1 overexpressed
1
E-GEOD-1956
R1
1
E-GEOD-21515
16 more value(s).


Cell type

studied in E-GEOD-2585, E-GEOD-19401, E-GEOD-2433, E-GEOD-5309, E-GEOD-21749, ... (24 experiments)

Factor Value U/D Experiments
in vitro pLN follicular dendritic cell
1
E-GEOD-19401
nontransformed thymocyte
1
E-GEOD-2501
T effector cell
1
E-GEOD-1419
type B spermatogonia
1
E-GEOD-4193
epithelial cell
1
E-GEOD-12618
type A spermatogonia
1
E-GEOD-4193
56 more value(s).


Disease state

studied in E-MEXP-1296, E-GEOD-21927, E-GEOD-21902, E-MEXP-1137, E-GEOD-2528, ... (9 experiments)

Factor Value U/D Experiments
healthy
1
E-GEOD-21927
EL-4 tumor-bearing
1
1
E-GEOD-21927
GM-CSF tumor-bearing
1
1
E-GEOD-21927
LPS-induced acute lung injury
1
1
E-GEOD-1871
monoclonal gammopathy of undetermined significance (MGUS)
1
E-GEOD-6980
tumor
1
E-GEOD-21902
9 more value(s).


Compound treatment

studied in E-GEOD-21711, E-TABM-903, E-GEOD-1301, E-GEOD-3296, E-TABM-310, ... (29 experiments)

Factor Value U/D Experiments
BMP
1
2
E-GEOD-18648, E-GEOD-18649
TGFb
2
E-GEOD-18649, E-GEOD-18648
cardiotoxin
2
E-GEOD-5304, E-MEXP-703
control
3
4
E-GEOD-21361, E-GEOD-484, E-TABM-903, E-GEOD-2788, E-GEOD-5324, ... (7 experiments)
MitC
1
E-MEXP-2209
1,5-naphthalenediamine
2
1
E-GEOD-5128
41 more value(s).


Agent

studied in E-GEOD-32706

Factor Value U/D Experiments
control
1
1
E-GEOD-32706


Amount to core
studied in E-GEOD-18858

Clinical info
studied in E-MEXP-1458

Clinical treatment
studied in E-GEOD-2411

Cohort
studied in E-GEOD-20524

Developmental stage
studied in E-GEOD-1026, E-GEOD-1479, E-GEOD-1867, E-GEOD-4870, E-GEOD-5305, ... (22 experiments)

Disease staging
studied in E-GEOD-17112

dose or concentration
studied in E-GEOD-18858

Family history
studied in E-GEOD-19194

Fraction
studied in E-TABM-363

Genetic modification
studied in E-GEOD-3172

Genotype
studied in E-GEOD-3822, E-GEOD-19684, E-GEOD-7020, E-MEXP-1649, E-GEOD-2746, ... (32 experiments)

Growth condition
studied in E-GEOD-1867, E-GEOD-495, E-GEOD-1776

Histology
studied in E-GEOD-15904

in vivo treatment
studied in E-GEOD-18858

Infection
studied in E-MEXP-1190, E-GEOD-17049, E-GEOD-21143, E-MEXP-1942

infection duration (days)
studied in E-GEOD-20524

infection status
studied in E-GEOD-20524

Irradiate
studied in E-GEOD-2084

Light
studied in E-TABM-285

Media
studied in E-MEXP-718

Observation
studied in E-GEOD-3594, E-GEOD-5296

Od260
studied in E-GEOD-18858

Organism
studied in E-MEXP-667

Phenotype
studied in E-GEOD-272, E-MEXP-1672, E-GEOD-2788, E-GEOD-2640, E-GEOD-19979 ... (5 experiments)

Protocol type
studied in E-GEOD-12293, E-GEOD-21389, E-GEOD-16192

Sampling time point
studied in E-GEOD-4356

Sex
studied in E-GEOD-6916

Stimulus or stress
studied in E-GEOD-15894, E-MEXP-1968, E-GEOD-15901

Strain or line
studied in E-GEOD-21515, E-MTAB-76, E-GEOD-20160, E-TABM-285, E-GEOD-3248, ... (6 experiments)

Treatment
studied in E-MTAB-76, E-GEOD-21902, E-GEOD-18344, E-GEOD-22009, E-MEXP-1899, ... (7 experiments)

Treatment repeat
studied in E-GEOD-18858

Treatment time
studied in E-GEOD-18858

Units of amount
studied in E-GEOD-18858

vehicle for chemical
studied in E-GEOD-18858

Processing time: 0.201 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM